Literature DB >> 19681888

Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure.

N Gunasekaran1, L E Long, B L Dawson, G H Hansen, D P Richardson, K M Li, J C Arnold, I S McGregor.   

Abstract

BACKGROUND AND
PURPOSE: Delta(9)-tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, accumulates in adipose tissue where it is stored for long periods of time. Here we investigated whether conditions that promote lipolysis can liberate THC from adipocytes to yield increased blood levels of THC. EXPERIMENTAL APPROACH: In vitro studies involved freshly isolated rat adipocytes that were incubated with THC before exposure to the lipolytic agent adrenocorticotrophic hormone (ACTH). A complementary in vivo approach examined the effects of both food deprivation and ACTH on blood levels of THC in rats that had been repeatedly injected with THC (10 mg.kg(-1)) for 10 consecutive days. Lipolysis promoted by ACTH or food deprivation was indexed by measurement of glycerol levels. KEY
RESULTS: ACTH increased THC levels in the medium of THC-pretreated adipocytes in vitro. ACTH also enhanced THC release from adipocytes in vitro when taken from rats repeatedly pretreated with THC in vivo. Finally, in vivo ACTH exposure and 24 h food deprivation both enhanced the levels of THC and its metabolite, (-)-11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THC-COOH) in the blood of rats that had been pre-exposed to repeated THC injections. CONCLUSIONS AND IMPLICATIONS: The present study shows that lipolysis enhances the release of THC from fat stores back into blood. This suggests the likelihood of 'reintoxication' whereby food deprivation or stress may raise blood THC levels in animals chronically exposed to the drug. Further research will need to confirm whether this can lead to functional effects, such as impaired cognitive function or 'flashbacks'.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19681888      PMCID: PMC2782342          DOI: 10.1111/j.1476-5381.2009.00399.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  [Cannabis-related flash-back, a medico-legal case].

Authors:  G Niveau
Journal:  Encephale       Date:  2002 Jan-Feb       Impact factor: 1.291

2.  METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.

Authors:  M RODBELL
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

3.  GC-MS-MS confirmation of unusually high delta 9-tetrahydrocannabinol levels in two postmortem blood samples.

Authors:  M Collins; J Easson; G Hansen; A Hodda; K Lewis
Journal:  J Anal Toxicol       Date:  1997 Nov-Dec       Impact factor: 3.367

4.  Increased sympathetic activity in rat white adipose tissue during prolonged fasting.

Authors:  R H Migliorini; M A Garofalo; I C Kettelhut
Journal:  Am J Physiol       Date:  1997-02

5.  Delta-9-tetrahydrocannabinol: localization in body fat.

Authors:  D S Kreuz; J Axelrod
Journal:  Science       Date:  1973-01-26       Impact factor: 47.728

6.  Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.

Authors:  A H Lichtman; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

7.  Studies on the hormone-sensitive lipase of adipose tissue.

Authors:  J P Schwartz; R L Jungas
Journal:  J Lipid Res       Date:  1971-09       Impact factor: 5.922

8.  The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism.

Authors:  B Xue; W O Wilkison; M B Zemel
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

Review 9.  Melanocortins and their receptors and antagonists.

Authors:  J Voisey; L Carroll; A van Daal
Journal:  Curr Drug Targets       Date:  2003-10       Impact factor: 3.465

10.  Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line.

Authors:  B A Boston; R D Cone
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

View more
  29 in total

1.  A hot mess: a case of hyperemesis.

Authors:  Eileen Cheung; Carly Ng; John Foote
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

2.  Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.

Authors:  Randi Melissa Schuster; Kevin Potter; Ryan Vandrey; Maya Hareli; Jodi Gilman; David Schoenfeld; A Eden Evins
Journal:  J Psychopharmacol       Date:  2019-09-19       Impact factor: 4.153

3.  The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions.

Authors:  Natalia I Brzozowska; Erik J de Tonnerre; Kong M Li; Xiao Suo Wang; Aurelie A Boucher; Paul D Callaghan; Michael Kuligowski; Alex Wong; Jonathon C Arnold
Journal:  Neuropsychopharmacology       Date:  2017-03-08       Impact factor: 7.853

4.  Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male Mice.

Authors:  Alexa Torrens; Valentina Vozella; Hannah Huff; Brandon McNeil; Faizy Ahmed; Andrea Ghidini; Stephen V Mahler; Marilyn A Huestis; Aditi Das; Daniele Piomelli
Journal:  J Pharmacol Exp Ther       Date:  2020-04-28       Impact factor: 4.030

5.  Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.

Authors:  Charlotte Klein; Emily Karanges; Adena Spiro; Alexander Wong; Jarrah Spencer; Thanh Huynh; Nathan Gunasekaran; Tim Karl; Leonora E Long; Xu-Feng Huang; Kelly Liu; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2011-06-11       Impact factor: 4.530

6.  Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction?

Authors:  Jennifer H Martin; Jennifer Schneider; Catherine J Lucas; Peter Galettis
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

7.  The novel cannabinoid CB1 receptor agonist AM11101 increases food intake in female rats.

Authors:  Sean B Ogden; Michael S Malamas; Alexandros Makriyannis; Lisa A Eckel
Journal:  Br J Pharmacol       Date:  2019-09-06       Impact factor: 8.739

Review 8.  Cannabinoid hyperemesis syndrome.

Authors:  Jonathan A Galli; Ronald Andari Sawaya; Frank K Friedenberg
Journal:  Curr Drug Abuse Rev       Date:  2011-12

Review 9.  The pharmacokinetics and the pharmacodynamics of cannabinoids.

Authors:  Catherine J Lucas; Peter Galettis; Jennifer Schneider
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

10.  Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences.

Authors:  Alexander Wong; Kirily Keats; Kieron Rooney; Callum Hicks; David J Allsop; Jonathon C Arnold; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.